-
1
-
-
0345600946
-
3 Therapy - Back to the Drawing Board
-
DOI 10.1001/jama.290.22.3002
-
Cooper DS. Combined T4 and T3 therapy: back to the drawing board. JAMA 2003; 290:3002-3004. (Pubitemid 37505535)
-
(2003)
Journal of the American Medical Association
, vol.290
, Issue.22
, pp. 3002-3004
-
-
Cooper, D.S.1
-
2
-
-
0242288751
-
Editorial: In search of the impossible dream? Thyroid hormone replacement therapy that treats all symptoms in all hypothyroid patients
-
DOI 10.1210/jc.2003-031436
-
Kaplan MM, Sarne DH, Schneider AB. Editorial: in search of the impossible dream? Thyroid hormone replacement therapy that treats all symptoms in all hypothyroid patients. J Clin Endocrinol Metab 2003; 88:4540-4542. (Pubitemid 37357489)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.10
, pp. 4540-4542
-
-
Kaplan, M.M.1
Sarne, D.H.2
Schneider, A.B.3
-
3
-
-
0023867084
-
Fine adjustment of thyroxine replacement dosage: Comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment
-
Carr D, McLeod DT, Parry G, et al. Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endocrinol 1988; 28:325-333. (Pubitemid 18079402)
-
(1988)
Clinical Endocrinology
, vol.28
, Issue.3
, pp. 325-333
-
-
Carr, D.1
McLeod, D.T.2
Parry, G.3
Thornes, H.M.4
-
4
-
-
18744419707
-
Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism
-
DOI 10.1056/NEJM199902113400603
-
Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 1999; 340:424-429. (Pubitemid 29084773)
-
(1999)
New England Journal of Medicine
, vol.340
, Issue.6
, pp. 424-429
-
-
Bunevicius, R.1
Kazanavicius, G.2
Zalinkevicius, R.3
Prange Jr., A.J.4
-
5
-
-
0034723754
-
The colorado thyroid disease prevalence study
-
Canaris GJ, Manowitz NR, Mayor GM, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Int Med 2000; 160:526-534. (Pubitemid 30112276)
-
(2000)
Archives of Internal Medicine
, vol.160
, Issue.4
, pp. 526-534
-
-
Canaris, G.J.1
Manowitz, N.R.2
Mayor, G.3
Ridgway, E.C.4
-
6
-
-
0025041194
-
The use and limitations of chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic
-
Ross DS, Daniels GH, Gouveia D. The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an outpatient endocrine clinic. J Clin Endocrinol Metab 1990; 71:764-769. (Pubitemid 20286081)
-
(1990)
Journal of Clinical Endocrinology and Metabolism
, vol.71
, Issue.3
, pp. 764-769
-
-
Ross, D.S.1
Danielg, G.H.2
Gouveia, D.3
-
7
-
-
0027481211
-
Thyroxine prescription in the community: Serum thyroid stimulating hormone level assays as an indicator of undertreatment of overtreatment
-
Parle JV, Franklyn JA, Cross KW, et al. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract 1993; 43:107-109. (Pubitemid 23121696)
-
(1993)
British Journal of General Practice
, vol.43
, Issue.368
, pp. 107-109
-
-
Parle, J.V.1
Franklyn, J.A.2
Cross, K.W.3
Jones, S.R.4
Sheppard, M.C.5
-
8
-
-
0036173697
-
4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
-
DOI 10.1210/jc.87.2.489
-
Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988-1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87:489-499. (Pubitemid 34158210)
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, Issue.2
, pp. 489-499
-
-
Hollowell, J.G.1
Staehling, N.W.2
Dana Flanders, W.3
Harry Hannon, W.4
Gunter, E.W.5
Spencer, C.A.6
Braverman, L.E.7
-
9
-
-
0036426814
-
Psychological well-being in patients on 'adequate' doses of L-thyroxine: Results of a large, controlled community-based questionnaire study
-
DOI 10.1046/j.1365-2265.2002.01654.x
-
Saravanan P, Chau F, Roberts N, et al. Psychological well being in patients on 'adequate' doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 2002; 57: 577-585. (Pubitemid 35316973)
-
(2002)
Clinical Endocrinology
, vol.57
, Issue.5
, pp. 577-585
-
-
Saravanan, P.1
Chau, W.-F.2
Roberts, N.3
Vedhara, K.4
Greenwood, R.5
Dayan, C.M.6
-
10
-
-
2342456501
-
Combined Levotriiodothyronine and Levothyroxine Therapy for Hypothyroidism: Are We a Step Closer to the Magic Formula?
-
DOI 10.1089/105072504323030898
-
Wartofsky L. Combined levotriiodothyronine and levothyroxine therapy for hypothyroidism: are we a step closer to the magic formula? Thyroid 2004; 14:247-248. (Pubitemid 38569273)
-
(2004)
Thyroid
, vol.14
, Issue.4
, pp. 247-248
-
-
Wartofsky, L.1
-
11
-
-
0029938145
-
Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat
-
DOI 10.1210/en.137.6.2490
-
Escobar-Morreale HF, Escobar del Rey FE, Obregon MJ, Morreale de Escobar G. Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology 1996; 137:2490-2502. (Pubitemid 26155786)
-
(1996)
Endocrinology
, vol.137
, Issue.6
, pp. 2490-2502
-
-
Escobar-Morreale, H.F.1
Del Rey, F.E.2
Obregon, M.J.3
De Escobar, G.M.4
-
12
-
-
0014953297
-
Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism
-
Smith RN, Taylor SA, Massey JC. Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism. Br Med J 1970; 4:145-148.
-
(1970)
Br Med J
, vol.4
, pp. 145-148
-
-
Smith, R.N.1
Taylor, S.A.2
Massey, J.C.3
-
13
-
-
0034632082
-
Excess triiodothyronine as a risk factor of coronary events
-
Peters A, Ehlers M, Blank B, et al. Excess triiodothyronine as a risk factor of coronary events. Arch Intern Med 2000; 160:1993-1999. (Pubitemid 30437583)
-
(2000)
Archives of Internal Medicine
, vol.160
, Issue.13
, pp. 1993-1999
-
-
Peters, A.1
Ehlers, M.2
Blank, B.3
Exler, D.4
Falk, C.5
Kohlmann, T.6
Fruchwald-Schultes, B.7
Wellhoener, P.8
Kerner, W.9
Fehm, H.L.10
-
14
-
-
0033545344
-
Thyroid hormone replacement - One hormone or two?
-
Toft AD. Thyroid hormone replacement: one hormone or two? N Engl J Med 1999; 340:469-470. (Pubitemid 29084781)
-
(1999)
New England Journal of Medicine
, vol.340
, Issue.6
, pp. 469-470
-
-
Toft, A.D.1
-
15
-
-
0345060920
-
Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: A randomized controlled trial
-
DOI 10.1001/jama.290.22.2952
-
Clyde PW, Harari AE, Getka EJ, Shakir KMM. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism. JAMA 2003; 290:2952-2958. (Pubitemid 37505527)
-
(2003)
Journal of the American Medical Association
, vol.290
, Issue.22
, pp. 2952-2958
-
-
Clyde, P.W.1
Harari, A.E.2
Getka, E.J.3
Shakir, K.M.M.4
-
16
-
-
0242288305
-
T4 plus T3 treatment for hypothyroidism: A double-blind comparison with usual T4
-
Los Angeles, CA
-
Levitt A, Silverberg J. T4 plus T3 treatment for hypothyroidism: a double-blind comparison with usual T4. Program 74th Annual Meeting, American Thyroid Association, Los Angeles, CA, 2002. Vol. 4 p. 112.
-
(2002)
Program 74th Annual Meeting, American Thyroid Association
, vol.4
, pp. 112
-
-
Levitt, A.1
Silverberg, J.2
-
17
-
-
0242288746
-
4 Alone in Patients with Hypothyroidism? Results of a Double-Blind, Randomized, Controlled Trial
-
DOI 10.1210/jc.2003-030139
-
Sawka AM, Gerstein HC, Marriott MJ, et al. Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a doubleblind, randomized, controlled trial. J Clin Endocrinol Metab 2003; 88:4551-4555. (Pubitemid 37357491)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.10
, pp. 4551-4555
-
-
Sawka, A.M.1
Gerstein, H.C.2
Marriott, M.J.3
MacQueen, G.M.4
Joffe, R.T.5
-
18
-
-
10744221589
-
Combined Thyroxine/Liothyronine Treatment Does Not Improve Well-Being, Quality of Life, or Cognitive Function Compared to Thyroxine Alone: A Randomized Controlled Trial in Patients with Primary Hypothyroidism
-
DOI 10.1210/jc.2003-030249
-
Walsh JP, Shiels L, Lim EM, et al. Combined thyroxine/liothyronine treatment does not improve well being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 2003; 88:4543-4550. (Pubitemid 37357490)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.10
, pp. 4543-4550
-
-
Walsh, J.P.1
Shiels, L.2
Lim, E.M.3
Bhagat, C.I.4
Ward, L.C.5
Stuckey, B.G.A.6
Dhaliwal, S.S.7
Chew, G.T.8
Bhagat, M.C.9
Cussons, A.J.10
-
19
-
-
0037967164
-
Treatment for congenital hypothyroidism: Thyroxine alone or thyroxine plus triiodothyronine?
-
DOI 10.1542/peds.111.5.1055
-
Cassio A, Cacciari E, Cicognani A, et al. Treatment for congenital hypothyroidism: thyroxine alone or thyroxine plus triiodothyronine? Pediatrics 2003; 111:1055-1060. (Pubitemid 36542621)
-
(2003)
Pediatrics
, vol.111
, pp. 1055-1060
-
-
Cassio, A.1
Cacciari, E.2
Cicognani, A.3
Damiani, G.4
Missiroli, G.5
Corbelli, E.6
Balsamo, A.7
Bal, M.8
Gualandi, S.9
-
20
-
-
14044272888
-
4 replacement therapy: Results of a large community-based randomized controlled trial
-
DOI 10.1210/jc.2004-1672
-
Saravanan P, Simmons DJ, Greenwood R, et al. Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial. J Clin Endocrinol Metab 2005; 90:805-812. (Pubitemid 40279201)
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.2
, pp. 805-812
-
-
Saravanan, P.1
Simmons, D.J.2
Greenwood, R.3
Peters, T.J.4
Dayan, C.M.5
-
21
-
-
18844405937
-
Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: A double-blind, randomized, controlled clinical trial
-
DOI 10.1210/jc.2004-2111
-
Appelhof BC, Fliers E, Wekking EM, et al. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab 2005; 90:2666-2674. (Pubitemid 40686307)
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.5
, pp. 2666-2674
-
-
Appelhof, B.C.1
Fliers, E.2
Wekking, E.M.3
Schene, A.H.4
Huyser, J.5
Tijssen, J.G.P.6
Endert, E.7
Van Weert, H.C.P.M.8
Wiersinga, W.M.9
-
22
-
-
14844339782
-
Thyroid hormone replacement therapy in primary hypothyroidism: A randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone
-
Escobar-Morreale HF, Botella-Carretero JI, Gómez-Bueno M, et al. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med 2005; 142:412-424.
-
(2005)
Ann Intern Med
, vol.142
, pp. 412-424
-
-
Escobar-Morreale, H.F.1
Botella-Carretero, J.I.2
Gómez-Bueno, M.3
-
23
-
-
33646439016
-
TSH and thyroid hormones concentrations in patients with hypothyroidism receiving replacement therapy with l-thyroxine alone or in combination with l-triiodothyronine
-
Fadeyev VV, Morgunova TB, Sytch JP, Melnichenko GA. TSH and thyroid hormones concentrations in patients with hypothyroidism receiving replacement therapy with l-thyroxine alone or in combination with l-triiodothyronine. Hormones 2005; 4:101-107.
-
(2005)
Hormones
, vol.4
, pp. 101-107
-
-
Fadeyev, V.V.1
Morgunova, T.B.2
Sytch, J.P.3
Melnichenko, G.A.4
-
24
-
-
34248677106
-
Effects of either LT4 monotherapy or LT4/LT3 combined therapy in patients totally thyroidectomized for thyroid cancer
-
DOI 10.1089/thy.2006.0084
-
Regalbuto C, Maiorana R, Alagona C, et al. Effects of either LT4 monotherapy or LT4/LT3 combined therapy in patients totally thyroidectomized for thyroid cancer. Thyroid 2007; 17:323-331. (Pubitemid 46776136)
-
(2007)
Thyroid
, vol.17
, Issue.4
, pp. 323-331
-
-
Regalbuto, C.1
Maiorana, R.2
Alagona, C.3
Di Paola, R.4
Cianci, M.5
Alagona, G.6
Sapienza, S.7
Squatrito, S.8
Pezzino, V.9
-
25
-
-
30444437570
-
Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: Effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone
-
Rodriguez T, Lavis VR, Meininger JC, et al. Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone. Endocr Pract 2005; 11:223-233.
-
(2005)
Endocr Pract
, vol.11
, pp. 223-233
-
-
Rodriguez, T.1
Lavis, V.R.2
Meininger, J.C.3
-
26
-
-
2942716790
-
Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14:1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism
-
DOI 10.1111/j.1365-2265.2004.02050.x
-
Siegmund W, Spieker K, Weike AI, et al. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14:1) is not superior to thyroxine alone to improve well being and cognitive performance in hypothyroidism. Clin Endocrinol 2004; 60:750-757. (Pubitemid 38788084)
-
(2004)
Clinical Endocrinology
, vol.60
, Issue.6
, pp. 750-757
-
-
Siegmund, W.1
Spieker, K.2
Weike, A.I.3
Giessmann, T.4
Modess, C.5
Dabers, T.6
Kirsch, G.7
Sanger, E.8
Engel, G.9
Hamm, A.O.10
Nauck, M.11
Meng, W.12
-
27
-
-
72849126078
-
Effect of combination therapy with thyroxine (T4) and 3,5,3'-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study
-
Nygaard B, Jensen EW, Kvetny J, et al. Effect of combination therapy with thyroxine (T4) and 3,5,3'-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study. Eur J Endocrinol 2009; 161:895-902.
-
(2009)
Eur J Endocrinol
, vol.161
, pp. 895-902
-
-
Nygaard, B.1
Jensen, E.W.2
Kvetny, J.3
-
28
-
-
33745768179
-
Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: Meta-analysis of randomized controlled trials
-
DOI 10.1210/jc.2006-0448
-
Grozinsky-Glasberg S, Fraser A, Nahshoni E, et al. Thyroxine- triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2006; 91:2592-2599. (Pubitemid 44024623)
-
(2006)
Journal of Clinical Endocrinology and Metabolism
, vol.91
, Issue.7
, pp. 2592-2599
-
-
Grozinsky-Glasberg, S.1
Fraser, A.2
Nahshoni, E.3
Weizman, A.4
Leibovici, L.5
-
29
-
-
68349113552
-
Thyroxine alone or thyroxine plus triiodothyronine replacement therapy for hypothyroidism
-
Ma C, Xie J, Huang X, et al. Thyroxine alone or thyroxine plus triiodothyronine replacement therapy for hypothyroidism. Nucl Med Commun 2009; 30:586-593.
-
(2009)
Nucl Med Commun
, vol.30
, pp. 586-593
-
-
Ma, C.1
Xie, J.2
Huang, X.3
-
30
-
-
34548291456
-
Treatment of clinical hypothyroidism with thyroxine and triiodothyronine: A literature review and metaanalysis
-
DOI 10.1176/appi.psy.48.5.379
-
Joffe RT, Brimacombe M, Levitt AJ, Stagnaro-Green A. Treatment of clinical hypothyroidism with thyroxine and triiodothyronine: a literature review and metaanalysis. Psychosomatics 2007; 48:379-384. (Pubitemid 47330290)
-
(2007)
Psychosomatics
, vol.48
, Issue.5
, pp. 379-384
-
-
Joffe, R.T.1
Brimacombe, M.2
Levitt, A.J.3
Stagnaro-Green, A.4
-
31
-
-
0033920253
-
Mental improvement after replacement therapy with thyroxine plus triiodothyronine: Relationship to cause of hypothyroidism
-
DOI 10.1017/S1461145700001826
-
Bunevicius R, Prange AJ Jr. Mental improvement after replacement therapy with thyroxine plus triiodothyronine: relationship to cause of hypothyroidism. Int J Neuropsychopharmacol 2000; 3:167-174. (Pubitemid 30429360)
-
(2000)
International Journal of Neuropsychopharmacology
, vol.3
, Issue.2
, pp. 167-174
-
-
Bunevicius, R.1
Prange Jr., A.J.2
-
32
-
-
0036658669
-
Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease
-
Bunevicius R, Jakuboniern N, Jurkevicius R, et al. Thyroxine vs. thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease. Endocr J 2002; 18:129-133.
-
(2002)
Endocr J
, vol.18
, pp. 129-133
-
-
Bunevicius, R.1
Jakuboniern, N.2
Jurkevicius, R.3
-
33
-
-
2342519483
-
Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: Proof of principle
-
DOI 10.1089/105072504323030924
-
Hennemann G, Docter R, Visser TJ, et al. Thyroxine plus low-dose, slowrelease triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid 2004; 14:271-275. (Pubitemid 38569276)
-
(2004)
Thyroid
, vol.14
, Issue.4
, pp. 271-275
-
-
Hennemann, G.1
Docter, R.2
Visser, T.J.3
Postema, P.T.4
Krenning, E.P.5
-
34
-
-
0025366287
-
Thyroidal and peripheral production of 3,5,3'-triiodothyronine in humans by multicompartmental analysis
-
Pilo A, Iervasi G, Vitek F, et al. Thyroidal and peripheral production of 3,5,3'- triiodothyronine in humans by multicompartmental analysis. Am J Physiol 1990; 258:E715-E726. (Pubitemid 20142356)
-
(1990)
American Journal of Physiology - Endocrinology and Metabolism
, vol.258
-
-
Pilo, A.1
Iervasi, G.2
Vitek, F.3
Ferdeghini, M.4
Cazzuola, F.5
Bianchi, R.6
-
35
-
-
0036191639
-
Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases
-
DOI 10.1210/er.23.1.38
-
Bianco AC, Salvatore D, Gereben B, et al. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002; 23:38-89. (Pubitemid 34185306)
-
(2002)
Endocrine Reviews
, vol.23
, Issue.1
, pp. 38-89
-
-
Bianco, A.C.1
Salvatore, D.2
Gereben, B.3
Berry, M.J.4
Larsen, P.R.5
-
36
-
-
39149116328
-
The clinical significance of subclinical thyroid dysfunction
-
DOI 10.1210/er.2006-0043
-
Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008; 29:76-131. (Pubitemid 351252748)
-
(2008)
Endocrine Reviews
, vol.29
, Issue.1
, pp. 76-131
-
-
Biondi, B.1
Cooper, D.S.2
-
37
-
-
76149115219
-
Age- and race-based serum thyrotropin reference limits
-
Surks MI, Boucai L. Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab 2010; 95:496-502.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 496-502
-
-
Surks, M.I.1
Boucai, L.2
-
38
-
-
0023199973
-
Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy
-
Liewendahl K, Helenius T, Lamberg BA, et al. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy. Acta Endocrinol (Copenh) 1987; 116:418-424. (Pubitemid 17154210)
-
(1987)
Acta Endocrinologica
, vol.116
, Issue.3
, pp. 418-424
-
-
Liewendahl, K.1
Helenius, T.2
Lamberg, B.-A.3
Mahonen, H.4
Wagar, G.5
-
39
-
-
0036123394
-
Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations
-
Woeber KA. 2002 Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. J Endocrinol Invest 2002; 25:106-109. (Pubitemid 34232608)
-
(2002)
Journal of Endocrinological Investigation
, vol.25
, Issue.2
, pp. 106-109
-
-
Woeber, K.A.1
-
40
-
-
39549097301
-
Triiodothyronine levels in athyreotic individuals during levothyroxine therapy
-
DOI 10.1001/jama.299.7.769
-
Jonklaas J, Davidson B, Bhagat S, Soldin SJ. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. JAMA 2008; 299:769-777. (Pubitemid 351281570)
-
(2008)
JAMA - Journal of the American Medical Association
, vol.299
, Issue.7
, pp. 769-777
-
-
Jonklaas, J.1
Davidson, B.2
Bhagat, S.3
Soldin, S.J.4
-
41
-
-
0023103073
-
Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism: Role of triiodothyronine in pituitary feedback in humans
-
Fish LH, Schwartz HL, Cavanaugh J, et al. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med 1987; 316: 764-770. (Pubitemid 17046084)
-
(1987)
New England Journal of Medicine
, vol.316
, Issue.13
, pp. 764-770
-
-
Fish, L.H.1
Schwartz, H.L.2
Cavanaugh, J.3
-
42
-
-
77149121414
-
Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer
-
Biondi B, Cooper DS. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid 2010; 20:135-146.
-
(2010)
Thyroid
, vol.20
, pp. 135-146
-
-
Biondi, B.1
Cooper, D.S.2
-
43
-
-
79960953366
-
Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients
-
Gullo D, Latina A, Frasca F, et al. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PLoS One 2011; 6: e22552.
-
(2011)
PLoS One
, vol.6
-
-
Gullo, D.1
Latina, A.2
Frasca, F.3
-
44
-
-
12244301591
-
A polymorphism in type I deiodinase is associated with circulating free insulin-like growth factor I levels and body composition in humans
-
DOI 10.1210/jc.2004-1301
-
Peeters RP, van den Beld AW, van Toor H, et al. A polymorphism in type I deiodinase is associated with circulating free insulin-like growth factor I levels and body composition in humans. J Clin Endocrinol Metab 2005; 90:256-263. (Pubitemid 40116666)
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.1
, pp. 256-263
-
-
Peeters, R.P.1
Van Den Beld, A.W.2
Van Toor, H.3
Uitterlinden, A.G.4
Janssen, J.A.M.J.L.5
Lamberts, S.W.J.6
Visser, T.J.7
-
45
-
-
0036317754
-
Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: Evidence of interaction with the Trp64Arg variant of the β-3-adrenergic receptor
-
Mentuccia D, Proietti-Pannunzi L, Tanner K, et al. Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Argvariant of the beta-3-adrenergic receptor. Diabetes 2002; 51:880-883. (Pubitemid 34760206)
-
(2002)
Diabetes
, vol.51
, Issue.3
, pp. 880-883
-
-
Mentuccia, D.1
Proietti-Pannunzi, L.2
Tanner, K.3
Bacci, V.4
Pollin, T.I.5
Poehlman, E.T.6
Shuldiner, A.R.7
Celi, F.S.8
-
46
-
-
33847082534
-
Ala92 type 2 deiodinase allele increases risk for the development of hypertension
-
Gumieniak O, Perlstein TS, Williams JS, et al. Ala92 type 2 deiodinase allele increases risk for the development of hypertension. Hypertension 2007; 49:461-466.
-
(2007)
Hypertension
, vol.49
, pp. 461-466
-
-
Gumieniak, O.1
Perlstein, T.S.2
Williams, J.S.3
-
47
-
-
78649690156
-
The Thr92Ala 5' type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropin-releasing hormone-stimulation test: A pharmacogenomic study
-
Butler PW, Smith SM, Linderman JD, et al. The Thr92Ala 5' type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropin-releasing hormone-stimulation test: a pharmacogenomic study. Thyroid 2010; 20:1407-1412.
-
(2010)
Thyroid
, vol.20
, pp. 1407-1412
-
-
Butler, P.W.1
Smith, S.M.2
Linderman, J.D.3
-
48
-
-
66149144319
-
Common variation in the DIO2 gene predicts baseline psychological well being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients
-
Panicker V, Saravanan P, Vaidya B, et al. Common variation in the DIO2 gene predicts baseline psychological well being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab 2009; 94:1623-1629.
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 1623-1629
-
-
Panicker, V.1
Saravanan, P.2
Vaidya, B.3
-
49
-
-
27744525730
-
Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3′- triiodothyronine therapy
-
DOI 10.1210/jc.2005-0451
-
Appelhof BC, Peeters RP, Wiersinga WM, et al. Polymorphisms in type 2deiodinase are not associated with well being, neurocognitive functioning, and preference for combined thyroxine/3,5,3'-triiodothyronine therapy. J Clin Endocrinol Metab 2005; 90:6296-6299. (Pubitemid 41606559)
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.11
, pp. 6296-6299
-
-
Appelhof, B.C.1
Peeters, R.P.2
Wiersinga, W.M.3
Visser, T.J.4
Wekking, E.M.5
Huyser, J.6
Schene, A.H.7
Tijssen, J.G.P.8
Hoogendijk, W.J.G.9
Fliers, E.10
-
50
-
-
67650330260
-
Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis
-
Heemstra KA, Hoftijzer HC, van der Deure WM, et al. Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis. Clin Endocrinol (Oxf) 2009; 71:279-283.
-
(2009)
Clin Endocrinol (Oxf)
, vol.71
, pp. 279-283
-
-
Heemstra, K.A.1
Hoftijzer, H.C.2
Van Der Deure, W.M.3
-
51
-
-
40849083521
-
Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients
-
DOI 10.1210/jc.2007-1067
-
Torlontano M, Durante C, Torrente I, et al. Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients. J Clin Endocrinol Metab 2008; 93:910-913. (Pubitemid 351398572)
-
(2008)
Journal of Clinical Endocrinology and Metabolism
, vol.93
, Issue.3
, pp. 910-913
-
-
Torlontano, M.1
Durante, C.2
Torrente, I.3
Crocetti, U.4
Augello, G.5
Ronga, G.6
Montesano, T.7
Travascio, L.8
Verrienti, A.9
Bruno, R.10
Santini, S.11
D'Arcangelo, P.12
Dallapiccola, B.13
Filetti, S.14
Trischitta, V.15
-
52
-
-
0033920253
-
Mental improvement after replacement therapy with thyroxine plus triiodothyronine: Relationship to cause of hypothyroidism
-
DOI 10.1017/S1461145700001826
-
Bunevicius R, Prange AJ. Mental improvement after replacement therapy with thyroxine plus triiodothyronine: relationship to cause of hypothyroidism. Int J Neuropsychopharmacol 2000; 3:167-174. (Pubitemid 30429360)
-
(2000)
International Journal of Neuropsychopharmacology
, vol.3
, Issue.2
, pp. 167-174
-
-
Bunevicius, R.1
Prange Jr., A.J.2
-
53
-
-
80052538824
-
The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma
-
Hoftijzer HC, Heemstra KA, Visser TJ, et al. The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma. J Clin Endocrinol Metab 2011; 96:E1527-E1533.
-
(2011)
J Clin Endocrinol Metab
, vol.96
-
-
Hoftijzer, H.C.1
Heemstra, K.A.2
Visser, T.J.3
-
54
-
-
77950269479
-
The pharmacodynamic equivalence of levothyroxine and liothyronine: A randomized, double blind, cross-over study in thyroidectomized patients
-
Celi FS, Zemskova M, Linderman JD, et al. The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients. Clin Endocrinol 2010; 72:709-715.
-
(2010)
Clin Endocrinol
, vol.72
, pp. 709-715
-
-
Celi, F.S.1
Zemskova, M.2
Linderman, J.D.3
-
55
-
-
80655145199
-
Metabolic effects of liothyronine therapy in hypothyroidism: A randomized, double-blind, crossover trial of liothyronine versus levothyroxine
-
Celi FS, Zemskova M, Linderman JD, et al. Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine. J Clin Endocrinol Metab 2011; 96: 3466-3474.
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 3466-3474
-
-
Celi, F.S.1
Zemskova, M.2
Linderman, J.D.3
-
56
-
-
84877712177
-
Desiccated thyroid extract compared to levothyroxine in the treatment of hypothyroidism: A randomized, double-blind, crossover study
-
Hoang TD, Olsen CH, Mai VQ, et al. Desiccated thyroid extract compared to levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab 2013; 98:1982-1990.
-
(2013)
J Clin Endocrinol Metab
, vol.98
, pp. 1982-1990
-
-
Hoang, T.D.1
Olsen, C.H.2
Mai, V.Q.3
-
58
-
-
84870784432
-
Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association
-
American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults.
-
Garber JR, Cobin RH, Gharib H, et al., American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid 2012; 22:1200-1235.
-
(2012)
Thyroid
, vol.22
, pp. 1200-1235
-
-
Garber, J.R.1
Cobin, R.H.2
Gharib, H.3
-
59
-
-
84883656699
-
Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American association of clinical endocrinologists and the american thyroid association
-
American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults.18:988-1028; Erratum in: Endocr Pract. Jan-Feb;
-
Garber JR, Cobin RH, Gharib H, et al., American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 2012; 18:988-1028; Erratum in: Endocr Pract. 2013 Jan-Feb;19:175.
-
(2013)
Endocr Pract 2012
, vol.19
, pp. 175
-
-
Garber, J.R.1
Cobin, R.H.2
Gharib, H.3
-
60
-
-
84883655713
-
Steady state serum T3 concentrations for 48 h following the oral administration of a single dose of T3 sulfate [abstract]
-
Endocrine Society
-
Santini F, Giannetti M, Ricco I, et al. Steady state serum T3 concentrations for 48 h following the oral administration of a single dose of T3 sulfate [abstract]. Endocrine Society 2013 Annual Meeting.
-
(2013)
Annual Meeting
-
-
Santini, F.1
Giannetti, M.2
Ricco, I.3
-
61
-
-
84871046753
-
Guidelines: The use of L-T4 + L-T3 in the treatment of hypothyroidism
-
An insightful editorial comment on the controversy
-
Wiersinga WM, Duntas L, Fadeyev V, et al.Guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J 2012; 1:55-57. An insightful editorial comment on the controversy.
-
(2012)
Eur Thyroid J
, vol.1
, pp. 55-57
-
-
Wiersinga, W.M.1
Duntas, L.2
Fadeyev, V.3
-
62
-
-
84877291070
-
European thyroid association guidelines on L-T4 + L-T3 combination for hypothyroidism: A weary step in the right direction
-
Perros P. European Thyroid Association Guidelines on L-T4 + L-T3 combination for hypothyroidism: a weary step in the right direction. Eur Thyroid J 2012; 1:51-54.
-
(2012)
Eur Thyroid J
, vol.1
, pp. 51-54
-
-
Perros, P.1
|